Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions
Manon Ragonnet-Cronin (),
Olivia Boyd,
Lily Geidelberg,
David Jorgensen,
Fabricia F. Nascimento,
Igor Siveroni,
Robert A. Johnson,
Marc Baguelin,
Zulma M. Cucunubá,
Elita Jauneikaite,
Swapnil Mishra,
Oliver J. Watson,
Neil Ferguson,
Anne Cori,
Christl A. Donnelly and
Erik Volz
Additional contact information
Manon Ragonnet-Cronin: Imperial College London
Olivia Boyd: Imperial College London
Lily Geidelberg: Imperial College London
David Jorgensen: Imperial College London
Fabricia F. Nascimento: Imperial College London
Igor Siveroni: Imperial College London
Robert A. Johnson: Imperial College London
Marc Baguelin: Imperial College London
Zulma M. Cucunubá: Imperial College London
Elita Jauneikaite: Imperial College London
Swapnil Mishra: Imperial College London
Oliver J. Watson: Imperial College London
Neil Ferguson: Imperial College London
Anne Cori: Imperial College London
Christl A. Donnelly: Imperial College London
Erik Volz: Imperial College London
Nature Communications, 2021, vol. 12, issue 1, 1-7
Abstract:
Abstract Unprecedented public health interventions including travel restrictions and national lockdowns have been implemented to stem the COVID-19 epidemic, but the effectiveness of non-pharmaceutical interventions is still debated. We carried out a phylogenetic analysis of more than 29,000 publicly available whole genome SARS-CoV-2 sequences from 57 locations to estimate the time that the epidemic originated in different places. These estimates were examined in relation to the dates of the most stringent interventions in each location as well as to the number of cumulative COVID-19 deaths and phylodynamic estimates of epidemic size. Here we report that the time elapsed between epidemic origin and maximum intervention is associated with different measures of epidemic severity and explains 11% of the variance in reported deaths one month after the most stringent intervention. Locations where strong non-pharmaceutical interventions were implemented earlier experienced much less severe COVID-19 morbidity and mortality during the period of study.
Date: 2021
References: Add references at CitEc
Citations: View citations in EconPapers (4)
Downloads: (external link)
https://www.nature.com/articles/s41467-021-22366-y Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22366-y
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-021-22366-y
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().